Bisacodyl VP (Fenolax) ,
Bisacodylum
Bisacodyl VP and Fenolax are different trade names for the same drug.
important information for the patient.
This medicine should always be used exactly as described in the patient leaflet or as directed by
your doctor.
Bisacodyl VP is a laxative and carminative.
It acts on the large intestine by:
You should consult a doctor, even if the above warnings refer to situations that occurred in the past.
Before starting to use Bisacodyl VP, you should discuss it with your doctor or pharmacist.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
Concomitant use of Bisacodyl VP with:
The information in this leaflet may also apply to medicines used in the past or those that will be used in the future.
Concomitant use of Bisacodyl VP with milk may increase the risk of stomach mucosa irritation. Bisacodyl VP should be taken at least 1 hour after drinking milk.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a child, you should consult a doctor or pharmacist before using this medicine.
Bisacodyl VP should not be used during pregnancy and breastfeeding, unless your doctor recommends otherwise.
Bisacodyl VP has no effect on the ability to drive vehicles and operate machinery.
If you have previously been diagnosed with intolerance to some sugars, you should consult a doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".
The medicine may cause allergic reactions.
This medicine should always be used exactly as described in the patient leaflet or as directed by
your doctor. If you are unsure, you should consult a doctor or pharmacist. The usual dose is:
Short-term treatment of constipation:
Adults and children over 10 years:
Orally, 5 mg to 10 mg (1 to 2 tablets) once a day (usually at night).
Children aged 4 to 10 years:
Orally, 5 mg (1 tablet) once a day (usually at night).
Emptying the intestine before diagnostic tests and surgical procedures: The medicine should be used under medical supervision.
Adults and children over 10 years:
Orally, 10 mg (2 tablets) in the morning and 10 mg (2 tablets) in the evening on the day before the test or procedure. Usually, on the day of the procedure, it is recommended to use bisacodyl rectally in the form of a suppository.
Children aged 4 to 10 years:
Orally, 5 mg (1 tablet) in the evening on the day before the test or procedure. Usually, on the day of the procedure, it is recommended to use bisacodyl rectally in the form of a suppository.
The elderly, patients with renal or hepatic impairment: No dose adjustment is necessary.
Bisacodyl is absorbed from the gastrointestinal tract in minimal amounts. Defecation usually occurs after about 6 hours after oral administration; after 6-12 hours if the medicine is taken before bedtime.
If you feel that the effect of the medicine is too strong or too weak, you should consult a doctor.
In children under 10 years of age with chronic constipation, the medicine should not be used without a doctor's recommendation.
The medicine should not be used in children under 4 years of age.
In people who have overdosed on bisacodyl, the following may occur: diarrhea, abdominal cramps, and water and electrolyte balance disorders that can cause increased potency of digitalis glycosides in patients taking them concomitantly, and other serious consequences. In case of overdose, you should contact a doctor.
If you miss a dose of the medicine at the scheduled time, you should take it as soon as possible.
However, if it is almost time for the next dose, you should skip the missed dose.
You should not take a double dose to make up for the missed dose.
If you have any further doubts about the use of the medicine, you should consult a doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very rare (less than 1 in 10,000 patients):
Frequency not known (frequency cannot be estimated from the available data):
If you experience any side effects, including any possible side effects not listed in the leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help provide more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C. Store in the original packaging.
Do not use this medicine after the expiry date stated on the carton after "Expiry date (Годен до)". The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Bisacodyl VP is available in the form of enteric-coated tablets. The packaging contains 30 tablets in a blister pack with Al/PVC foil in a cardboard box.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Mylan EOOD
“Serdika Offices” Office building
48, Sitnyakovo Blvd., 7 floor
1505 Sofia
Bulgaria
ICN Polfa Rzeszów S.A.
ul. Przemysłowa 2
35-959 Rzeszów
Poland
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
CEFEA Sp. z o.o. Sp. komandytowa
ul. Działkowa 56
02-234 Warszawa
Pharma Innovations Sp. z o.o.
ul. Jagiellońska 76
03-301 Warszawa
Synoptis Industrial Sp. z o.o.
ul. Szosa Bydgoska 58
87-100 Toruń
CANPOLAND SPÓŁKA AKCYJNA
ul. Beskidzka 190
91-610 Łódź
Number of the marketing authorization in Bulgaria, the country of export: 9800198
Number of the parallel import authorization: 294/22
Date of approval of the leaflet: 28.07.2022
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.